This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571) Demographics of Users, Social & Digital Divide (739)

Published on in Vol 11, No 12 (2022): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38878, first published .
The Japan Registry for Adult Subjects of Spinal Muscular Atrophy (jREACT-SMA): Protocol for a Longitudinal Observational Study

The Japan Registry for Adult Subjects of Spinal Muscular Atrophy (jREACT-SMA): Protocol for a Longitudinal Observational Study

The Japan Registry for Adult Subjects of Spinal Muscular Atrophy (jREACT-SMA): Protocol for a Longitudinal Observational Study

Authors of this article:

Kentaro Sahashi1 Author Orcid Image ;   Atsushi Hashizume2 Author Orcid Image ;   Yachiyo Kuwatsuka3 Author Orcid Image ;   Madoka Chinen4 Author Orcid Image ;   Ai Saotome-Nakamura4 Author Orcid Image ;   Masahiko Ando3 Author Orcid Image ;   Masahisa Katsuno1, 2 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics

Journals

  1. Tachibana Y, Sato R, Makioka H, Hoshino M, Jin M. Safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 524 patients: results from an interim analysis of post-marketing surveillance in Japan. International Journal of Neuroscience 2023:1 View
  2. Yao X, Peng J, Luo R, Wang X, Lu X, Wu L, Jin R, Zhong J, Liang J, Hong S, Yang L, Zhang X, Mao S, Hu J, Tao Z, Sun D, Wang H, Zhang L, Xia Y, Chen K, Wang Y. Nusinersen effectiveness and safety in pediatric patients with 5q-spinal muscular atrophy: a multi-center disease registry in China. Journal of Neurology 2024;271(8):5378 View